These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network. Kishore A; Popa T Front Neurol; 2014; 5():157. PubMed ID: 25183959 [TBL] [Abstract][Full Text] [Related]
7. Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias. Ponzo V; Picazio S; Benussi A; Di Lorenzo F; Brusa L; Caltagirone C; Koch G Mov Disord; 2016 May; 31(5):755-9. PubMed ID: 26861941 [TBL] [Abstract][Full Text] [Related]
9. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias. Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805 [TBL] [Abstract][Full Text] [Related]
10. Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease. Kishore A; Popa T; Velayudhan B; Joseph T; Balachandran A; Meunier S Brain; 2012 Jul; 135(Pt 7):2074-88. PubMed ID: 22609619 [TBL] [Abstract][Full Text] [Related]
11. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias. Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853 [TBL] [Abstract][Full Text] [Related]
12. The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias. Cerasa A; Donzuso G; Morelli M; Mangone G; Salsone M; Passamonti L; Augimeri A; Arabia G; Quattrone A Mov Disord; 2015 Dec; 30(14):1912-20. PubMed ID: 26275050 [TBL] [Abstract][Full Text] [Related]
13. Altered brain structural topological properties in Parkinson's disease with levodopa-induced dyskinesias. Wang L; Wang M; Si Q; Yuan Y; Ma K; Gan C; Zhang K Parkinsonism Relat Disord; 2019 Oct; 67():36-41. PubMed ID: 31621605 [TBL] [Abstract][Full Text] [Related]
15. Neuroplasticity in levodopa-induced dyskinesias: An overview on pathophysiology and therapeutic targets. Bove F; Angeloni B; Sanginario P; Rossini PM; Calabresi P; Di Iorio R Prog Neurobiol; 2024 Jan; 232():102548. PubMed ID: 38040324 [TBL] [Abstract][Full Text] [Related]
16. Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson's Disease. Ferrucci R; Cortese F; Bianchi M; Pittera D; Turrone R; Bocci T; Borroni B; Vergari M; Cogiamanian F; Ardolino G; Di Fonzo A; Padovani A; Priori A Cerebellum; 2016 Feb; 15(1):43-47. PubMed ID: 26542731 [TBL] [Abstract][Full Text] [Related]
17. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038 [TBL] [Abstract][Full Text] [Related]
18. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries. Lewis MM; Slagle CG; Smith AB; Truong Y; Bai P; McKeown MJ; Mailman RB; Belger A; Huang X Neuroscience; 2007 Jun; 147(1):224-35. PubMed ID: 17499933 [TBL] [Abstract][Full Text] [Related]
19. Bilateral low frequency rTMS of the primary motor cortex may not be a suitable treatment for levodopa-induced dyskinesias in late stage Parkinson's disease. Flamez A; Cordenier A; De Raedt S; Michiels V; Smetcoren S; Van Merhaegen-Wieleman A; Parys E; De Keyser J; Baeken C Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26777410 [TBL] [Abstract][Full Text] [Related]
20. Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Hershey T; Black KJ; Stambuk MK; Carl JL; McGee-Minnich LA; Perlmutter JS Proc Natl Acad Sci U S A; 1998 Sep; 95(20):12016-21. PubMed ID: 9751782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]